Sinopharm Group Co Ltd banner

Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 21.5 HKD 2.77% Market Closed
Market Cap: HK$67.1B

Multiples-Based Value

The Multiples-Based Value for Sinopharm Group Co Ltd (1099) under the Base Case is 123.7 HKD. Compared with the current market price of 21.5 HKD, the stock appears Undervalued by 83%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Multiples-Based Value
Base Case
123.7 HKD
Undervaluation 83%
Multiples-Based Value
Price HK$21.5
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Sinopharm Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sinopharm Group Co Ltd
HKEX:1099
67.1B HKD 0.1 8.4 0.8 1
US
Mckesson Corp
NYSE:MCK
107.2B USD 0.3 24.7 17.4 19.5
US
Cencora Inc
NYSE:COR
63.2B USD 0.2 38.9 13.8 17.4
US
Amerisourcebergen Corp
LSE:0HF3
62.3B USD 0.2 38.3 13.6 17.1
US
Cardinal Health Inc
NYSE:CAH
50.8B USD 0.2 30.5 14.7 19.2
AU
Sigma Healthcare Ltd
ASX:SIG
31.1B AUD 2.7 34.1 25.3 25.3
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.1B CNY 0.2 11.2 8.7 8.7
CN
Huadong Medicine Co Ltd
SZSE:000963
63.6B CNY 1.5 17.2 13.3 13.3
US
Henry Schein Inc
NASDAQ:HSIC
8.7B USD 0.7 22 10.8 15.3
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
AU
EBOS Group Ltd
OTC:EBOSY
7.7B USD 0.9 48.7 32.1 32.1
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett